Spontaneous bacterial empyema

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 4, 2012, Pages 355-358

  Tu, Chih Yen ^a,b,c   Chen, Chia Hung ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cirrhosis; hepatic hydrothorax; MELD Na score; spontaneous bacterial empyema

Indexed keywords

CARBAPENEM; CEPHALOSPORIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM EXAMINATION; CHILD PUGH SCORE; CLINICAL ASSESSMENT TOOL; EARLY DIAGNOSIS; ECHOGRAPHY; EMPYEMA; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; MODEL FOR END STAGE LIVER DISEASE SODIUM; MORTALITY; OUTCOME ASSESSMENT; PATHOGENESIS; PREDICTION; REVIEW; SCORING SYSTEM; SPONTANEOUS BACTERIAL EMPYEMA; TREATMENT FAILURE; TUBE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; EMPYEMA; HOSPITAL MORTALITY; HUMANS; HYDROTHORAX; LIVER CIRRHOSIS; PROGNOSIS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 84862168971     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328352b50f     Document Type: Review

References (34)

1. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28:26-42.
2. Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: Epidemiologic changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-148.
3. Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. J Chin Med Assoc 2003; 66:579-586.
4. Chen CH, Shih CM, Chou JW, et al. Outcome predictors of cirrhotic patients with spontaneous bacterial empyema. Liver Int 2011; 31:417-424.Until now studies have not specifically looked for outcome predictors in hospitalized SBEM patients. This study uses regression analysis to identify three factors affecting the outcomes in hospitalized SBEM patients.
5. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: A retrospective review in two military hospitals. Chest 1993; 103:1502-1507.
6. Varkey B, Rose HD, Kutty CP, et al. Empyema thoracis during a ten-year period. Analysis of 72 cases and comparison to a previous study (1952-1967). Arch Intern Med 1981; 141:1771-1776.
7. Kirchmair R, Allerberger F, Bangerl I, et al. Spontaneous bacterial pleural empyema in liver cirrhosis. Dig Dis Sci 1998; 43:1129-1132.
8. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17:231.
9. Sese E, Xiol X, Castellote J, et al. Low complement levels and opsonic activity in hepatic hydrothorax: Its relationship with spontaneous bacterial empyema. J Clin Gastroenterol 2003; 36:75-77.
10. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25:619-622.
11. Roussos A, Philippou N, Mantzaris GJ, et al. Hepatic hydrothorax: Pathophysiology, diagnosis and management. J Gastroenterol Hepatol 2007; 22:1388-1393.
12. Xiol X, Castellote J, Baliellas C, et al. Spontaneous bacterial empyema in cirrhotic patients: Analysis of eleven cases. Hepatology 1990; 11:365-370.
13. Xiol X, Castellote J, Baliettas C, et al. Spontaneous bacterial empyema in cirrhotic patients: A prospective study. Hepatology 1996; 23:719-723.
14. Tsai TH, Yang PC. Ultrasound in the diagnosis and management of pleural disease. Curr Opin Pulm Med 2003; 9:282-290.
15. Diacon AH, Theron J, Bolliger CT. Transthoracic ultrasound for the pulmonologist. Curr Opin Pulm Med 2005; 11:307-312.
16. Simmers TA, Jie C, Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg 1999; 47:77-81.
17. Jones PW, Moyers JP, Rogers JT, et al. Ultrasound-guided thoracentesis: Is it a safer method? Chest 2003; 123:418-423.
18. Diacon AH, Brutsche MH, Soler M. Accuracy of pleural puncture sites: A prospective comparison of clinical examination with ultrasound. Chest 2003; 123:436-441.
19. Xiol X, Castellote J, Cortes-Beut R, et al. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med 2001; 111:67-69.
20. Chapman SJ, Davies RJ. Recent advances in parapneumonic effusions and empyema. Curr Opin Pulm Med 2004; 10:299-304.
21. Heo J, Seo YS, Yim HJ, et al. Clinical features and prognosis of spontaneous bacterial peritonitis in Korean patients with liver cirrhosis: A multicenter retrospective study. Gut Liver 2009; 3:197-204.
22. Castellote J, Ariza J, Girbau A, et al. Risk factors to cefotaxime-resistant spontaneous bacterial peritonitis. J Hepatol 2010; 52:S69. This study identify risk factors of cefotaxime-resistant pathogens in spontaneous bacterial peritonitis.
23. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409.
24. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest 2000; 118:1158-1171.
25. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81:566-577.
26. Alberts WM, Salem AJ, Solomon DA, et al. Hepatic hydrothorax: Cause and management. Arch Intern Med 1991; 151:2383-2388.
27. Orman ES, Lok AS.Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3:582-586.
28. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
29. Srikureja W, Kyulo NL, Runyon BA, et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42:700-706.
30. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005; 42 (Suppl 1):S100-S107.
31. Mishra P, Desai N, Alexander J, et al. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: An Indian experience. J Gastroenterol Hepatol 2007; 22:1232-1235.
32. Neuberger J. Allocation of donor livers: Is MELD enough? Liver Transpl 2004; 10:908-910.
33. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11:336-343.
34. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40:802-810.